← All organizations

Protagonist Therapeutics

For profitWebsite ↗

Also known as: Protagonist Therapeutics | Protagonist Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 8, 2025

Timeline

2000s

Jun 1, 2001
Protagonist Therapeutics— Founded

Drugs by trial phase (6 distinct, 14 trials)

Phase 3 (1 own, 0 via acquisition)

ptg-300

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT07153146Lead sponsorPhase 1Sep 8, 2025
NCT06033586Lead sponsorPhase 3Dec 1, 2023
NCT05210790Lead sponsorPhase 3Apr 1, 2022
NCT04819620Lead sponsorPhase 1May 13, 2021
NCT04767802Lead sponsorPhase 2Feb 2, 2021
NCT04621630Lead sponsorPhase 1Nov 30, 2020
NCT04524221CollaboratorPhase 1Sep 30, 2020
NCT04516382Study directorPhase 1Sep 14, 2020
NCT04516382Lead sponsorPhase 1Sep 14, 2020
NCT04504383Lead sponsorPhase 2Aug 5, 2020
NCT04202965Lead sponsorPhase 2Jan 2, 2020
NCT04057040Lead sponsorPhase 2Aug 31, 2019
NCT04054921Lead sponsorPhase 2May 10, 2019
NCT03802201Lead sponsorPhase 2Dec 19, 2018
NCT02895100Lead sponsorPhase 2Dec 1, 2016

Details

Founded: Brisbane, AU Jun 1, 2001
Last known activity: Sep 8, 2025